Macular edema is the condition when
the fluid and proteins start collecting on or under the macula of the eye
thereby resulting in swelling. Due to such swelling, a person’s central
eye vision gets distorted. Macular edema is classified into two types namely
cystoids macular edema (CME) and diabetic macular edema (DME).
Visit Complete Report Here: http://www.marketresearchreports.biz/analysis-details/diabetic-macular-edema-market-global-industry-analysis-size-share-growth-trends-and-forecast-2013-2019
Diabetic macular edema is the major
reason for loss of vision in patients suffering from diabetic retinopathy.
Diabetes patient are reported to have a 10% risk of developing this condition
during their lifetime. On the basis of the cause of disease, DME is classified
into two types:
Diffuse macular edema: due to
abnormalities in dilated capillaries present in the retina.
Focal macular edema: due to
abnormalities in microaneurysms
For diagnosing diabetic macular
edema, an ophthalmologist checks the retina for symptoms of the disease
including leaking blood vessel, retinal swelling, damaged nerve tissues and
pale, fatty deposits on the retina. For further confirmation, comprehensive
eye examination such as visual acuity test, dilated exam test and tonometry
are performed.
During the initial stages of DME,
no treatment is needed unless the patients efficiently control their blood
sugar levels. If the condition becomes severe, the standard treatment for
diabetic macular edema is laser photocoagulation. This procedure utilizes
laser to reduce edema byapplying a pattern of burnsor bycauterizing leaky
blood vessels. For avoiding the side-effects of this treatment, retinal
specialists apply injections of anti-vascular endothelial growth
factorcorticosteroids along with laser photocoagulation. Currently, there are
only two approved drugs available in market for treating DME namely Lucentis
and Ozurdex. Other treatment methods are currently under clinical
trials.
The markets for America and Europe
are at the maturity stage for diabetic macular edema because large proportion
of population is suffering from diabetes. Lucentis and Ozurdex ocuppy the
major part of the market share in the therapeutics market. Asia-Pacific is
also growing at faster pace while the markets of Africa and Australia are
currently at initial stages. Some of the companies and institutes which are
involved in clinical trials for treatment of diabetic macular edema are
Allergan, Inc., Novartis AG, F. Hoffmann-La Roche Ltd., Regeneron
Pharmaceuticals, Inc., Pfizer, Inc.,Bayer AG, Bausch & Lomb
Incorporated,the Diabetic Retinopathy Clinical Research Network, The National
Eye Institute, Johns Hopkins University and ShahidBeheshti University of
Medical Sciences.
This research report analyzes this
market depending on its market segments, major geographies, and current market
trends. Geographies analyzed under this research report include
- North America
- Asia Pacific
- Europe
- Rest of the World
This report provides comprehensive
analysis of
- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for
upcoming years
This report is a complete study of
current trends in the market, industry growth drivers, and restraints. It
provides market projections for the coming years. It includes analysis of
recent developments in technology, Porter’s five force model analysis and
detailed profiles of top industry players. The report also includes a review
of micro and macro factors essential for the existing market players and new
entrants along with detailed value chain analysis.
Reasons for Buying this Report
- This report provides pin-point
analysis for changing competitive dynamics
- It provides a forward looking
perspective on different factors driving or restraining market
growth
- It provides a technological
growth map over time to understand the industry growth rate
- It provides a seven-year
forecast assessed on the basis of how the market is predicted to
grow
- It helps in understanding the
key product segments and their future
- It provides pin point analysis
of changing competition dynamics and keeps you ahead of competitors
- It helps in making informed
business decisions by having complete insights of market and by making
in-depth analysis of market segments
- It provides distinctive
graphics and exemplified SWOT analysis of major market segments
Contact US: 
|
Office: United States
|
|
State Tower
90 State Street, Suite 700 Albany, NY 12207 United States |
No comments:
Post a Comment